Nippon India Pharma Fund-Growth Plan-Growth Option Invest Now
Fund Manager: Sailesh Raj Bhan    |     Equity: Sectoral-Pharma and Healthcare    |     S&P BSE Healthcare TRI

257.9313 -3.65 (-1.42 %)

NAV as on 15-01-2021

4,383.33 Cr

AUM as on 31-12-2020

Rtn ( Since Inception )

21.59%

Inception Date

Jun 01, 2004

Expense Ratio

2.05%

Fund Status

Open Ended Scheme

Min. Investment

5,000

Min. Topup

1,000

Min. SIP Amount

100

Risk Status

high

Investment Objective : The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

Want to continue the conversation?

Speak to our expert in

Leave your email below and we will assign a personal Relationship Manager to get in touch and start aligning your life goals